These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36472428)

  • 21. Population genetics of the nomenspecies Enterobacter cloacae.
    Hoffmann H; Roggenkamp A
    Appl Environ Microbiol; 2003 Sep; 69(9):5306-18. PubMed ID: 12957918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a novel, biofilm dispersing, lytic bacteriophage against drug-resistant Enterobacter cloacae.
    Nair A; Vyawahare R; Khairnar K
    J Appl Microbiol; 2022 Apr; 132(4):2721-2732. PubMed ID: 34927785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial and anti-biofilm activities of paeonol against
    Qian W; Li X; Yang M; Mao G
    Biofouling; 2021 Jul; 37(6):666-679. PubMed ID: 34320877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential of phage cocktails in the inactivation of Enterobacter cloacae--An in vitro study in a buffer solution and in urine samples.
    Pereira S; Pereira C; Santos L; Klumpp J; Almeida A
    Virus Res; 2016 Jan; 211():199-208. PubMed ID: 26541317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The differential importance of mutations within AmpD in cephalosporin resistance of Enterobacter aerogenes and Enterobacter cloacae.
    Babouee Flury B; Ellington MJ; Hopkins KL; Turton JF; Doumith M; Woodford N
    Int J Antimicrob Agents; 2016 Nov; 48(5):555-558. PubMed ID: 27665520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic characterization of tigecycline resistance in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.
    Veleba M; De Majumdar S; Hornsey M; Woodford N; Schneiders T
    J Antimicrob Chemother; 2013 May; 68(5):1011-8. PubMed ID: 23349441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of transcriptional activators SoxS, RobA, and RamA on expression of multidrug efflux pump AcrAB-TolC in Enterobacter cloacae.
    Pérez A; Poza M; Aranda J; Latasa C; Medrano FJ; Tomás M; Romero A; Lasa I; Bou G
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6256-66. PubMed ID: 23006750
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Souna D; Drissi M; Almahmoud I; Maurin M
    Microb Drug Resist; 2022 Mar; 28(3):346-354. PubMed ID: 34890283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic and biological characteristics of a newly isolated lytic bacteriophage PZJ0206 infecting the Enterobacter cloacae.
    Li Z; Wang W; Ma B; Yin J; Hu C; Luo P; Wang Y
    Virus Res; 2022 Jul; 316():198800. PubMed ID: 35577174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colistin resistance in Enterobacter spp. isolates in Korea.
    Hong YK; Lee JY; Ko KS
    J Microbiol; 2018 Jun; 56(6):435-440. PubMed ID: 29858832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First Report of the Colistin Resistance Gene
    Guan J; Li L; Zheng L; Lu G; Wang Y; Lakoh S; Sevalie S; Jiang B; Ji X; Sun Y; Liu J; Zhu L; Guo X
    Microbiol Spectr; 2022 Aug; 10(4):e0112722. PubMed ID: 35695522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive description of the TolC effect on the antimicrobial susceptibility profile in
    Li B; Zhang J; Li X
    Front Cell Infect Microbiol; 2022; 12():1036933. PubMed ID: 36569193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome Characterization of the Novel Lytic Enterobacter cloacae Phage vB_EclM_Q7622.
    Tan S; Huang S; Liu Z; Chen M; Chen H; Ye Q; Wu S; Yang X; Zhang S; Zhang J; Wu Q; Yang M
    Food Environ Virol; 2023 Sep; 15(3):236-245. PubMed ID: 37306924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced efficacy of imipenem-colistin combination therapy against multiple-drug-resistant Enterobacter cloacae: in vitro activity and a Galleria mellonella model.
    Yang H; Chen G; Hu L; Liu Y; Cheng J; Ye Y; Li J
    J Microbiol Immunol Infect; 2018 Feb; 51(1):70-75. PubMed ID: 26906264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergism between WLBU2 peptide and antibiotics against methicillin-resistant Staphylococcus aureus and extended-spectrum beta-lactamase-producing Enterobacter cloacae.
    Elsalem L; Al Sheboul S; Khasawneh A
    J Appl Biomed; 2021 Mar; 19(1):14-25. PubMed ID: 34907712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dosing and dosing frequency on the efficacy of ceftizoxime and the emergence of ceftizoxime resistance during the early development of murine abscesses caused by Bacteroides fragilis and Enterobacter cloacae mixed infection.
    Stearne LE; Goessens WH; Mouton JW; Gyssens IC
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3605-11. PubMed ID: 17646416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First report of CTX-M-9 in a clinical isolate of Enterobacter cloacae in a Tunisian hospital.
    Bourouis A; Dubois V; Coulange L; André C; Bejhadj C; Ben Moussa M; Quentin C; Belhadj O
    Pathol Biol (Paris); 2011 Aug; 59(4):187-91. PubMed ID: 19481370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete Sequence of pCY-CTX, a Plasmid Carrying a Phage-Like Region and an ISEcp1-Mediated Tn2 Element from Enterobacter cloacae.
    Xu Z; Xie J; Yang L; Chen D; Peters BM; Shirtliff ME
    Microb Drug Resist; 2018 Apr; 24(3):307-313. PubMed ID: 28876168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colistin Susceptibility in Companion Animal-Derived
    Sato T; Harada K; Usui M; Yokota SI; Horiuchi M
    Front Cell Infect Microbiol; 2022; 12():946841. PubMed ID: 35873176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The biological activity of antibacterial substance produced by Enterobacter cloacae B8.
    Ya-Ping J; Wei-liang C; Rong Z; Bai-rong Z
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2003; 13(2):115-20. PubMed ID: 14509942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.